Raymond James Downgrades 89bio Inc. (ETNB) to Market Perform Sep 19, 2025 06:50AM
H.C. Wainwright Downgrades 89bio Inc. (ETNB) to Neutral Sep 19, 2025 06:02AM
Wolfe Research Downgrades 89bio Inc. (ETNB) to Peerperform Sep 19, 2025 03:15AM
UBS Reiterates Buy Rating on 89bio Inc. (ETNB) Following Agreement to be Acquired by Roche Sep 18, 2025 09:14AM
Roche to acquire 89bio for up to $20.50 per share in $3.5 billion deal Sep 18, 2025 05:59AM


Sep 18, 2025 01:06AM Roche To Buy US-listed 89bio For $14.50/shr
Sep 4, 2025 06:13AM H.C. Wainwright Starts 89bio Inc. (ETNB) at Buy
Aug 8, 2025 08:39AM 89bio Inc. (ETNB) PT Lowered to $11 at RBC Capital
Aug 7, 2025 04:14PM 89bio, Inc. (ETNB) Misses Q2 EPS by 21c
Aug 7, 2025 03:39PM 89bio Inc. (ETNB) November 10 and 12.50 calls active, share price down 5.9%
May 2, 2025 10:20AM 89bio Inc. (ETNB) PT Lowered to $55 at Cantor Fitzgerald
May 1, 2025 05:12PM 89bio, Inc. (ETNB) Tops Q1 EPS by 3c
Mar 14, 2025 04:18AM Goldman Sachs Starts 89bio Inc. (ETNB) at Neutral
Mar 3, 2025 08:41AM Cantor Fitzgerald Reiterates Overweight Rating on 89bio Inc. (ETNB)
Mar 3, 2025 06:41AM 89bio Inc. (ETNB) PT Lowered to $21 at H.C. Wainwright
Feb 28, 2025 07:42AM Cantor Fitzgerald Reiterates Overweight Rating on 89bio Inc. (ETNB)
Feb 27, 2025 05:10PM 89bio, Inc. (ETNB) Misses Q4 EPS by 27c
Feb 3, 2025 05:37AM 89bio Inc. (ETNB) PT Raised to $37 at Leerink Partners
Jan 27, 2025 04:56PM After-hours movers: Nucor, Graco, 89bio Inc
Jan 27, 2025 04:12PM 89bio Inc. (ETNB) Announces Proposed $250M Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Jan 21, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on 89bio Inc. (ETNB)
Nov 15, 2024 08:06AM 89bio Inc. (ETNB) Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH
Nov 13, 2024 06:26AM 89bio Inc. (ETNB) Prices 11.46M Share Offering at $8.5/sh
Nov 12, 2024 04:02PM 89bio Inc. (ETNB) Announces Proposed $100M Share Offering
Nov 8, 2024 06:34AM 89bio, Inc. (ETNB) Misses Q3 EPS by 77c
Sep 4, 2024 04:16PM 89bio Inc. (ETNB) Announces Two Supervisory Board Additions
Aug 7, 2024 08:02AM 89bio Inc. (ETNB) Appoints Francis Sarena as COO
Aug 6, 2024 06:41AM 89bio Inc. (ETNB) PT Lowered to $12 at RBC Capital
Aug 5, 2024 05:38PM 89bio, Inc. (ETNB) Tops Q2 EPS by 8c
Aug 5, 2024 08:04AM 89bio Inc. (ETNB) Appoints Charles McWherter to its Board